Pharmaceutical giant Mylan acquires ARV drugs manufacturing plant in South Africa
Global pharmaceutical company Mylan on Tuesday announced the acquisition of a manufacturing site, previously owned by Ascendis Health, for its plans to produce high-quality antiretrovirals for seven million South Africans living with HIV.
Spread over an expanse of 2.34 ha, the facility at Isando in Johannesburg has the capacity to produce regular pills, effervescent tablets, semi solid and hard gelatin capsules.
Mylan said it had committed significant investment to acquire the facility, which would create job opportunities for the local population.
It said it would create a state-of-the-art manufacturing center for antiretrovirals and upskill the local team to global standards.
Mylan president Rajiv Malik said the company's global HIV initiative was one of its key priorities, representing a continued commitment to give patients in low- and middle-income countries with access to medicines.
"Mylan's innovations have helped fuel a steep decline in ARV drug costs over the last decade, and the integration of the Isando site into our global manufacturing network will help us to meet unmet patient needs in South Africa," Malik said.
"Mylan has invested significantly in its scientific platform and created broad capacity for global ARV supply. With our scale, excellent formulation chemistry skills, process optimization and cutting-edge quality systems, Mylan is committed to continue setting new standards in healthcare the world over."
Mylan supplies ARV drugs to more than 100 countries around the world. The company is among the largest suppliers of ARV medicines in South Africa both in the private and public sectors.
Comments
The
functionality
you are trying to access is only available to subscribers.
If you are already a subscriber, you can Login Here.
If you are not a subscriber, you can subscribe now, by selecting one of the below options.
For more information or assistance, please contact us at subscriptions@creamermedia.co.za.
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation